{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:07:18Z","timestamp":1790885238618,"version":"4.1.0"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ejpb.2026.115005","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T16:15:12Z","timestamp":1769271312000},"page":"115005","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Re-purposed phenobarbital-loaded squarticles: A novel approach for the topical management of chemotherapy-induced alopecia\u201c"],"prefix":"10.1016","volume":"221","author":[{"given":"Salma A.","family":"Fereig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8714-3087","authenticated-orcid":false,"given":"John","family":"Youshia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9524-140X","authenticated-orcid":false,"given":"Ghada M.","family":"El-Zaafarany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6070-3267","authenticated-orcid":false,"given":"Mona G.","family":"Arafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4017-1248","authenticated-orcid":false,"given":"Mona M.A.","family":"Abdel-Mottaleb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2026.115005_b0005","unstructured":"Global cancer burden growing, amidst mounting need for services. World Health Organization [Internet]. 2024 Feb; Available from: https:\/\/www.who.int\/news\/item\/01-02-2024-global-cancer-burden-growing--amidst-mounting-need-for-services#:\u223c:text=In%202022%2C%20there%20were%20an,women%20die%20from%20the%20disease."},{"issue":"6","key":"10.1016\/j.ejpb.2026.115005_b0010","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S1470-2045(19)30163-9","article-title":"Estimates of global chemotherapy demands and corresponding physician workforce requirements for 2018 and 2040: a population-based study","volume":"20","author":"Wilson","year":"2019","journal-title":"Lancet Oncol."},{"issue":"3","key":"10.1016\/j.ejpb.2026.115005_b0015","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1634\/theoncologist.2018-0184","article-title":"Permanent chemotherapy\u2010induced alopecia in patients with breast cancer: a 3\u2010year prospective cohort study","volume":"24","author":"Kang","year":"2019","journal-title":"Oncologist"},{"issue":"101","key":"10.1016\/j.ejpb.2026.115005_b0020","article-title":"Perilous consequences of chemotherapy induced alopecia in afflicted cancer survivors: a comprehensive state of the art review","volume":"1","author":"Fereig","year":"2024","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.ejpb.2026.115005_b0025","doi-asserted-by":"crossref","unstructured":"W.L. Weston, A.T. Lane, J.G. Morelli, Chapter 1 - Structure and Function of the Skin. In: Weston WL, Lane AT, Morelli JG, editors. Color Textbook of Pediatric Dermatology (Fourth Edition) [Internet]. Edinburgh: Mosby; 2007. pp. 1\u20139. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/B9780323049092500047.","DOI":"10.1016\/B978-0-323-04909-2.50004-7"},{"issue":"4","key":"10.1016\/j.ejpb.2026.115005_b0030","doi-asserted-by":"crossref","first-page":"656","DOI":"10.9738\/INTSURG-D-14-00227.1","article-title":"Topical N-acetylcysteine improves wound healing comparable to dexpanthenol: an experimental study","volume":"100","author":"Oguz","year":"2015","journal-title":"Int. Surg."},{"issue":"8","key":"10.1016\/j.ejpb.2026.115005_b0035","first-page":"543","article-title":"Chemotherapy-induced alopecia: psychosocial impact and therapeutic approaches","volume":"12","author":"Hesketh","year":"2004","journal-title":"Support. Care Cancer"},{"issue":"11","key":"10.1016\/j.ejpb.2026.115005_b0040","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1007\/s11095-006-9105-3","article-title":"Protection against chemotherapy-induced alopecia","volume":"23","author":"Wang","year":"2006","journal-title":"Pharm. Res."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115005_b0045","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nrm3270","article-title":"The unfolded protein response: controlling cell fate decisions under ER stress and beyond","volume":"13","author":"Hetz","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"7","key":"10.1016\/j.ejpb.2026.115005_b0050","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1634\/theoncologist.2012-0332","article-title":"Factors influencing the effectiveness of scalp cooling in the prevention of chemotherapy\u2010induced alopecia","volume":"18","author":"Komen","year":"2013","journal-title":"Oncologist"},{"key":"10.1016\/j.ejpb.2026.115005_b0055","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/epi.12026","article-title":"How phenobarbital revolutionized epilepsy therapy: the story of phenobarbital therapy in epilepsy in the last 100 years","volume":"53","author":"Yasiry","year":"2012","journal-title":"Epilepsia"},{"issue":"10","key":"10.1016\/j.ejpb.2026.115005_b0060","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/phar.2017","article-title":"Repurposing valproate, enteral clonidine, and phenobarbital for comfort in adult ICU patients: a literature review with practical considerations","volume":"37","author":"Gagnon","year":"2017","journal-title":"Pharmacother. J. Human Pharmacol. DrugTherap."},{"key":"10.1016\/j.ejpb.2026.115005_b0065","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00228-020-03011-x","article-title":"Pharmacokinetic variability of phenobarbital: a systematic review of population pharmacokinetic analysis","volume":"77","author":"Methaneethorn","year":"2021","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.ejpb.2026.115005_b0070","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/BF02327074","article-title":"Effect of topically applied phenobarbital on O-dealkylase activity in mouse skin","volume":"38","author":"Pannatier","year":"1982","journal-title":"Experientia"},{"issue":"7","key":"10.1016\/j.ejpb.2026.115005_b0075","doi-asserted-by":"crossref","DOI":"10.3390\/ph18071071","article-title":"Chitosan nanoparticles for topical drug delivery in chemotherapy-induced alopecia: a comparative study of five repurposed pharmacological agents","volume":"18","author":"Fereig","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejpb.2026.115005_b0080","doi-asserted-by":"crossref","unstructured":"K. Engle K, G. Kumar . Cancer multidrug-resistance reversal by ABCB1 inhibition: a recent update. European J. Medicinal Chem., 2022, 239:114542.","DOI":"10.1016\/j.ejmech.2022.114542"},{"key":"10.1016\/j.ejpb.2026.115005_b0085","article-title":"Differential expression and functionality of ATP binding cassette transporters in the human hair follicle","author":"Haslam","year":"2014","journal-title":"Br. J. Dermatol."},{"issue":"593","key":"10.1016\/j.ejpb.2026.115005_b0090","article-title":"Thiolated and PEGylated silica nanoparticle delivery to hair follicles","volume":"25","author":"Al Mahrooqi","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"203","key":"10.1016\/j.ejpb.2026.115005_b0095","article-title":"Opportunities of topical drug products in a changing dermatological landscape","volume":"1","author":"Hsiao","year":"2024","journal-title":"Eur. J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115005_b0100","doi-asserted-by":"crossref","DOI":"10.3390\/cosmetics7020021","article-title":"Topical minoxidil-loaded nanotechnology strategies for alopecia","volume":"7","author":"Santos","year":"2020","journal-title":"Cosmetics"},{"issue":"4","key":"10.1016\/j.ejpb.2026.115005_b0105","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/17425255.2024.2337749","article-title":"Clinical pharmacokinetics and pharmacodynamics of topical non-biological therapies for psoriasis patients","volume":"20","author":"Lo","year":"2024","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115005_b0110","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1208\/s12248-013-9550-y","article-title":"Squarticles as a lipid nanocarrier for delivering diphencyprone and minoxidil to hair follicles and human dermal papilla cells","volume":"16","author":"Aljuffali","year":"2014","journal-title":"AAPS J."},{"issue":"12","key":"10.1016\/j.ejpb.2026.115005_b0115","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.3390\/pharmaceutics12121131","article-title":"Tofacitinib loaded squalenyl nanoparticles for targeted follicular delivery in inflammatory skin diseases","volume":"12","author":"Christmann","year":"2020","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115005_b0120","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1016\/j.jdermsci.2016.08.183","article-title":"Squarticles as a nanocarrier for targeting minoxidil to hair follicles and dermal papilla cells","volume":"84","author":"Fang","year":"2016","journal-title":"J. Dermatol. Sci."},{"issue":"6","key":"10.1016\/j.ejpb.2026.115005_b0125","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.nano.2015.04.009","article-title":"Anti-PDGF receptor \u03b2 antibody-conjugated squarticles loaded with minoxidil for alopecia treatment by targeting hair follicles and dermal papilla cells","volume":"11","author":"Aljuffali","year":"2015","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115005_b0130","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.ejpb.2008.05.008","article-title":"Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC)","volume":"70","author":"Fang","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2026.115005_b0135","article-title":"Combination of calcipotriol and methotrexate in nanostructured lipid carriers for topical delivery","volume":"117\u201328","author":"Lin","year":"2010","journal-title":"Int. J. Nanomed."},{"issue":"5","key":"10.1016\/j.ejpb.2026.115005_b0140","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1080\/02652048.2020.1756970","article-title":"Development and characterisation of clobetasol propionate loaded Squarticles as a lipid nanocarrier for treatment of plaque psoriasis","volume":"37","author":"Dadwal","year":"2020","journal-title":"J. Microencapsul."},{"issue":"9","key":"10.1016\/j.ejpb.2026.115005_b0145","doi-asserted-by":"crossref","first-page":"991","DOI":"10.4155\/tde.14.61","article-title":"Delivery and targeting of nanoparticles into hair follicles","volume":"5","author":"Fang","year":"2014","journal-title":"Ther. Deliv."},{"issue":"20","key":"10.1016\/j.ejpb.2026.115005_b0150","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.3390\/molecules25204781","article-title":"Preparation of solid lipid nanoparticles and nanostructured lipid carriers for drug delivery and the effects of preparation parameters of solvent injection method","volume":"25","author":"Duong","year":"2020","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.ejpb.2026.115005_b0155","first-page":"161","article-title":"Green formulation of spironolactone loaded chitosan-coated nano lipid carrier for treatment of acne vulgaris: a randomized double-blind clinical trial","volume":"14","author":"Saeedi","year":"2024","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.ejpb.2026.115005_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121114","article-title":"Self-assembled tacrolimus-loaded lecithin-chitosan hybrid nanoparticles for in vivo management of psoriasis","volume":"608","author":"Fereig","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115005_b0165","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/697937","article-title":"Stability-indicating assay for the determination of pentobarbital sodium in liquid formulations","volume":"2015","author":"Ajemni","year":"2015","journal-title":"Int. J. Anal. Chem."},{"issue":"608","key":"10.1016\/j.ejpb.2026.115005_b0170","article-title":"Design of long acting invasomal nanovesicles for improved transdermal permeation and bioavailability of asenapine maleate for the chronic treatment of schizophrenia","volume":"25","author":"El-Tokhy","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115005_b0175","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.908386","article-title":"Novel phenobarbital-loaded nanostructured lipid carriers for epilepsy treatment: from QbD to in vivo evaluation","volume":"10","author":"Scioli-Montoto","year":"2022","journal-title":"Front. Chem."},{"key":"10.1016\/j.ejpb.2026.115005_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.118238","article-title":"Tacrolimus-loaded chitosan nanoparticles for enhanced skin deposition and management of plaque psoriasis","volume":"268","author":"Fereig","year":"2021","journal-title":"Carbohydr. Polym."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115005_b0185","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ejpb.2012.06.006","article-title":"Nanoparticles enhance therapeutic outcome in inflamed skin therapy","volume":"82","author":"Abdel-Mottaleb","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115005_b0190","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1046\/j.0022-202X.2003.22120.x","article-title":"Topical estrogen accelerates hair regrowth in mice after chemotherapy-induced alopecia by favoring the dystrophic catagen response pathway to damage","volume":"122","author":"Ohnemus","year":"2004","journal-title":"J. Invest. Dermatol."},{"issue":"11","key":"10.1016\/j.ejpb.2026.115005_b0195","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1016\/j.febslet.2010.04.058","article-title":"p53-dependent transcriptional regulation of EDA2R and its involvement in chemotherapy-induced hair loss","volume":"584","author":"Brosh","year":"2010","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejpb.2026.115005_b0200","unstructured":"W. Underwood, R. Anthony, AVMA guidelines for the euthanasia of animals: 2020 ed., Retrieved on March, 2020;2013(30):2020\u20131."},{"issue":"35","key":"10.1016\/j.ejpb.2026.115005_b0205","first-page":"1","article-title":"Safety of polysorbate 80 in the oncology setting","volume":"1","author":"Schwartzberg","year":"2018","journal-title":"Adv. Ther."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115005_b0210","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1039\/D2BM01454H","article-title":"A lipid\u2013polymer hybrid nanoparticle (LPN)-loaded dissolving microneedle patch for promoting hair regrowth by transdermal miR-218 delivery","volume":"11","author":"Zhao","year":"2023","journal-title":"Biomater. Sci."},{"issue":"4","key":"10.1016\/j.ejpb.2026.115005_b0215","first-page":"126","article-title":"Garlic antagonizes skeletal muscle ischemia reperfusion injury through regulating inflammation, apoptosis and desmin expression in adult male rats","volume":"11","author":"Abd El-Mottaleb","year":"2019","journal-title":"Int. J. Physiol. Pathophysiol. Pharmacol."},{"issue":"126","key":"10.1016\/j.ejpb.2026.115005_b0220","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijbiomac.2018.12.135","article-title":"Hair growth-promoting activities of chitosan and surface-deacetylated chitin nanofibers","volume":"1","author":"Azuma","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"issue":"4","key":"10.1016\/j.ejpb.2026.115005_b0225","doi-asserted-by":"crossref","first-page":"4354","DOI":"10.1021\/acsnano.8b09573","article-title":"A Therapeutic microneedle patch made from hair-derived keratin for promoting hair regrowth","volume":"13","author":"Yang","year":"2019","journal-title":"ACS Nano"},{"issue":"4","key":"10.1016\/j.ejpb.2026.115005_b0230","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1053\/j.semnuclmed.2009.03.006","article-title":"Genomic biomarkers for molecular imaging: predicting the future","volume":"39","author":"Thakur","year":"2009","journal-title":"Semin. Nucl. Med."},{"issue":"3","key":"10.1016\/j.ejpb.2026.115005_b0235","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/JID.2015.358","article-title":"Development of a model for chemotherapy-induced alopecia: profiling of histological changes in human hair follicles after chemotherapy","volume":"136","author":"Yoon","year":"2016","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ejpb.2026.115005_b0240","first-page":"106","article-title":"A novel approach for the development of a nanostructured lipid carrier formulation by hot-melt extrusion technology","volume":"1","author":"Bhagurkar","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115005_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.jid.2023.04.015","article-title":"Studying hair growth cycle and its effects on mouse skin","author":"Wang","year":"2023","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115005_b0250","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.0022-202x.2001.01377.x","article-title":"A comprehensive guide for the accurate classification of murine hair follicles in distinct hair cycle stages","volume":"117","author":"M\u00fcller-R\u00f6ver","year":"2001","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115005_b0255","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.0022-202X.2005.23787.x","article-title":"A guide to assessing damage response pathways of the hair follicle: lessons from cyclophosphamide-induced alopecia in mice","volume":"125","author":"Hendrix","year":"2005","journal-title":"J. Invest. Dermatol."},{"issue":"7","key":"10.1016\/j.ejpb.2026.115005_b0260","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/exd.12182","article-title":"Pretreatment of epidermal growth factor promotes primary hair recovery via the dystrophic anagen pathway after chemotherapy-induced alopecia","volume":"22","author":"Paik","year":"2013","journal-title":"Exp. Dermatol."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115005_b0265","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.1523-1747.2003.12022.x","article-title":"Fas and c-kit are involved in the control of hair follicle melanocyte apoptosis and migration in chemotherapy-induced hair loss","volume":"120","author":"Sharov","year":"2003","journal-title":"J. Invest. Dermatol."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115005_b0270","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jid.2020.05.118","article-title":"Inhibition of Shh signaling through MAPK activation controls chemotherapy-induced alopecia","volume":"141","author":"Haslam","year":"2021","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ejpb.2026.115005_b0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.archoralbio.2022.105454","article-title":"Molecular biology exploration and targeted therapy strategy of Ameloblastoma","volume":"140","author":"Lu","year":"2022","journal-title":"Arch. Oral Biol."},{"issue":"3","key":"10.1016\/j.ejpb.2026.115005_b0280","doi-asserted-by":"crossref","first-page":"893","DOI":"10.3390\/jcm12030893","article-title":"Integrative and mechanistic approach to the hair growth cycle and hair loss","volume":"12","author":"Natarelli","year":"2023","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115005_b0285","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejpb.2011.04.009","article-title":"Lipid nanocapsules for dermal application: a comparative study of lipid-based versus polymer-based nanocarriers","volume":"79","author":"Abdel-Mottaleb","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2026.115005_b0290","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1208\/s12249-010-9563-0","article-title":"Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery","volume":"12","author":"Das","year":"2011","journal-title":"AAPS PharmSciTech"},{"issue":"3","key":"10.1016\/j.ejpb.2026.115005_b0295","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ejpb.2009.12.008","article-title":"Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics","volume":"74","author":"Chen","year":"2010","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"133","key":"10.1016\/j.ejpb.2026.115005_b0300","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ejpb.2018.10.017","article-title":"Solid lipid nanoparticles and nanostructured lipid carriers: a review emphasizing on particle structure and drug release","volume":"1","author":"Gordillo-Galeano","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"11","key":"10.1016\/j.ejpb.2026.115005_b0305","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.3390\/pharmaceutics13111950","article-title":"Biocompatibility and antimicrobial activity of nanostructured lipid carriers for topical applications are affected by type of oils used in their composition","volume":"13","author":"de Barros","year":"2021","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.ejpb.2026.115005_b0310","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2174\/1872210517666230120142439","article-title":"Nanostructured lipid carriers (NLCs) as effective drug delivery systems: methods of preparation and their therapeutic applications","volume":"18","author":"Alatawi","year":"2024","journal-title":"Recent Pat. Nanotechnol."},{"key":"10.1016\/j.ejpb.2026.115005_b0315","article-title":"Safety assessment of lecithin and other phosphoglycerides as used in cosmetics","volume":"39(2_suppl):5S\u201325S","author":"Johnson","year":"2020","journal-title":"Int. J. Toxicol."},{"issue":"3","key":"10.1016\/j.ejpb.2026.115005_b0320","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1021\/cr9400976","article-title":"Comparative QSAR: toward a deeper understanding of chemicobiological interactions","volume":"96","author":"Hansch","year":"1996","journal-title":"Chem. Rev."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115005_b0325","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s12668-024-01624-5","article-title":"Multivariate optimization of carbamazepine-loaded nanostructured lipid carriers for brain targeting and epilepsy management","volume":"15","author":"Patel","year":"2024","journal-title":"BioNanoScience"},{"issue":"Suppl 2","key":"10.1016\/j.ejpb.2026.115005_b0330","first-page":"563","article-title":"Encapsulation of vitamin a palmitate in nanostructured lipid carrier (NLC)-effect of surfactant concentration on the formulation properties","volume":"4","author":"Pezeshki","year":"2014","journal-title":"Adv. Pharmaceut. Bull."},{"issue":"2","key":"10.1016\/j.ejpb.2026.115005_b0335","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5530\/ijpi.2019.2.10","article-title":"Investigative study on impact of solid: liquid lipid ratio and stabilizer amount on some characteristics of nanostructure lipid carriers of quetiapine fumarate","volume":"9","author":"Agarwal","year":"2019","journal-title":"Int. J..Pharm. Invest."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115005_b0340","article-title":"Formulation design, production and characterisation of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for the encapsulation of a model hydrophobic active","volume":"1","author":"Sakellari","year":"2021","journal-title":"Food Hydrocoll. Health"},{"key":"10.1016\/j.ejpb.2026.115005_b0345","article-title":"Nanostructured lipid carriers (NLCs) of lumefantrine with enhanced permeation","volume":"1\u201314","author":"Shevalkar","year":"2021","journal-title":"J. Pharm. Innov."},{"issue":"61","key":"10.1016\/j.ejpb.2026.115005_b0350","article-title":"Repositioning miconazole nitrate for malaria: formulation of sustained release nanostructured lipid carriers, structure characterization and in vivo antimalarial evaluation","volume":"1","author":"Umeyor","year":"2021","journal-title":"J. Drug Delivery Sci. Technol."},{"issue":"151","key":"10.1016\/j.ejpb.2026.115005_b0355","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijbiomac.2020.02.143","article-title":"Dutasteride nanocapsules for hair follicle targeting: effect of chitosan-coating and physical stimulus","volume":"15","author":"Ushirobira","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"issue":"12","key":"10.1016\/j.ejpb.2026.115005_b0360","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.3390\/pharmaceutics16121524","article-title":"Evaluation of dutasteride-loaded liposomes and transfersomes for follicular-targeting for androgenic alopecia topical treatment","volume":"16","author":"Andrade","year":"2024","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.ejpb.2026.115005_b0365","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4161\/derm.1.2.8472","article-title":"Sebaceous gland lipids","volume":"1","author":"Picardo","year":"2009","journal-title":"Dermato-Endocrinol."},{"key":"10.1016\/j.ejpb.2026.115005_b0370","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1023\/A:1018922114398","article-title":"Site-specific drug delivery to pilosebaceous structures using polymeric microspheres","volume":"10","author":"Rolland","year":"1993","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.ejpb.2026.115005_b0375","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.0022-202X.2004.22717.x","article-title":"Penetration profile of microspheres in follicular targeting of terminal hair follicles","volume":"123","author":"Toll","year":"2004","journal-title":"J. Invest. Dermatol."},{"issue":"5","key":"10.1016\/j.ejpb.2026.115005_b0380","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000066249","article-title":"Penetration of titanium dioxide microparticles in a sunscreen formulation into the horny layer and the follicular orifice","volume":"12","author":"Lademann","year":"1999","journal-title":"Skin Pharmacol. Physiol."},{"issue":"6","key":"10.1016\/j.ejpb.2026.115005_b0385","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/sj.jid.5700226","article-title":"40 nm, but not 750 or 1,500 nm, nanoparticles enter epidermal CD1a+ cells after transcutaneous application on human skin","volume":"126","author":"Vogt;","year":"2006","journal-title":"J. Invest. Dermatol."},{"issue":"6","key":"10.1016\/j.ejpb.2026.115005_b0390","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1634\/theoncologist.2017-0396","article-title":"Ki67 changes identify worse outcomes in residual breast cancer tumors after neoadjuvant chemotherapy","volume":"23","author":"Cabrera-Galeana","year":"2018","journal-title":"Oncologist"},{"issue":"5","key":"10.1016\/j.ejpb.2026.115005_b0395","doi-asserted-by":"crossref","first-page":"e655","DOI":"10.1016\/j.clbc.2022.02.001","article-title":"Changes in Ki-67 in Residual tumor and outcome of primary inflammatory breast cancer treated with trimodality therapy","volume":"22","author":"Song","year":"2022","journal-title":"Clin. Breast Cancer"},{"issue":"17","key":"10.1016\/j.ejpb.2026.115005_b0400","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1016\/j.ejca.2003.07.002","article-title":"In vitro cytoprotective activity of squalene on a bone marrow versus neuroblastoma model of cisplatin-induced toxicity: implications in cancer chemotherapy","volume":"39","author":"Das","year":"2003","journal-title":"Eur. J. Cancer"},{"issue":"10","key":"10.1016\/j.ejpb.2026.115005_b0405","doi-asserted-by":"crossref","DOI":"10.1593\/neo.08466","article-title":"Squalene selectively protects mouse bone marrow progenitors against cisplatin and carboplatin-induced cytotoxicity in vivo without protecting tumor growth","volume":"10","author":"Das","year":"2008","journal-title":"Neoplasia"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126000263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126000263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T09:34:30Z","timestamp":1770284070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641126000263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":81,"alternative-id":["S0939641126000263"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115005","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Re-purposed phenobarbital-loaded squarticles: A novel approach for the topical management of chemotherapy-induced alopecia\u201c","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115005"}}